- Advertisement -spot_img

TAG

Eli Lilly

Eli Lilly introduces Ramiven® (abemaciclib) in India, for certain high-risk early breast cancer patients

Abemaciclib is a CDK4/6 inhibitor which has now been approved for HR+ HER2 - node positive high risk early breast cancer. New Delhi, November 24,...

Latest news

- Advertisement -spot_img